MYCN and neoplasm: They felt that there were opposing functions of PP2A gene expression that may be dose dependent; first, as an essential survival gene when expressed in low amounts, and second, as a tumor suppressor when expressed at high levels, and that tumors required a low amount of PP2A to support other oncogenes such as MYCN [9].